Ibandronate increases sclerostin levels and bone strength in male patients with idiopathic osteoporosis.
about
Preceding and subsequent high- and low-trauma fracture patterns-a 13-year epidemiological study in females and males in Austria.The role of sclerostin/dickkopf-1 and receptor activator of nuclear factor kB ligand/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: A cross-sectional study.Bone-related Circulating MicroRNAs miR-29b-3p, miR-550a-3p, and miR-324-3p and their Association to Bone Microstructure and Histomorphometry.Screening of differentially expressed genes in male idiopathic osteoporosis via RNA sequencing.
P2860
Ibandronate increases sclerostin levels and bone strength in male patients with idiopathic osteoporosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Ibandronate increases sclerost ...... with idiopathic osteoporosis.
@en
Ibandronate increases sclerost ...... with idiopathic osteoporosis.
@nl
type
label
Ibandronate increases sclerost ...... with idiopathic osteoporosis.
@en
Ibandronate increases sclerost ...... with idiopathic osteoporosis.
@nl
prefLabel
Ibandronate increases sclerost ...... with idiopathic osteoporosis.
@en
Ibandronate increases sclerost ...... with idiopathic osteoporosis.
@nl
P2093
P2860
P50
P1476
Ibandronate increases sclerost ...... with idiopathic osteoporosis.
@en
P2093
Alexandra Kaider
Barbara M Misof
Christian Muschitz
Heinrich Resch
Peter Pietschmann
Roland Kocijan
P2860
P2888
P304
P356
10.1007/S00223-015-0003-8
P407
P577
2015-04-25T00:00:00Z